Demo Sign up Log In

Nurix Therapeutics Inc (NRIX)

Cash Conversion Ratio

1.12×

Quarterly · Period ending: Aug 31, 2026

NRIX Cash Conversion Ratio

Latest reported1.12×period endingAug 31, 2026

Latest reported1.12×period endingAug 31, 2026

NRIX Quarterly Cash Conversion Ratio (3.67× → 1.12×)

Latest values, visible window

High-resolution chart · PNG

NRIX cash conversion ratio history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Nurix Therapeutics Inc Cash Conversion Ratio — Quarterly
Period ending	Cash Conversion Ratio
Aug 31, 2026	1.1172×
May 31, 2026	1.1002×
Feb 28, 2026	0.8369×
Nov 30, 2025	0.9328×
Aug 31, 2025	0.6954×
May 31, 2025	1.5147×
Feb 28, 2025	1.1459×
Nov 30, 2024	0.8686×
Aug 31, 2024	0.9095×
May 31, 2024	0.9348×
Feb 29, 2024	1.0799×
Nov 30, 2023	-0.5745×
Aug 31, 2023	1.1787×
May 31, 2023	0.8052×
Feb 28, 2023	1.2454×
Nov 30, 2022	0.8674×
Aug 31, 2022	1.0879×
May 31, 2022	0.7864×
Feb 28, 2022	1.0839×
Nov 30, 2021	0.8427×
Aug 31, 2021	1.1041×
May 31, 2021	1.2746×
Feb 28, 2021	-0.297×
Nov 30, 2020	1.074×
Aug 31, 2020	0.4218×
May 31, 2020	-2.1164×
Feb 29, 2020	-3.2772×
Nov 30, 2019	1.0135×
Aug 31, 2019	-14.7833×
May 31, 2019	4.3631×
Feb 28, 2019	3.6655×

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.